AORT Gunggung Aset Perusahaan Artivion Inc

Total assets by ROA demonstrate the fundamental trajectory of Artivion, Inc. (AORT), with the latest reading standing at 957.58. R&D expenses and potential product quality claims are constraining growth. However, success is based on regulatory approvals and demand for stents, while the high complexity of tissue cryopreservation creates a powerful defensive barrier against new entrants in the cardiac surgery niche.

Artivion Inc - Total Aset Perusahaan AORT (periode 04.07.2022 - 01.11.2026)

Rincian metrik keuangan lan pasar Artivion Inc (AORT)

- rega saham lan prakiraan rega para ahli:

Rega artivion.com|AORT - Bagan rega target

- data kapitalisasi pasar:

Kapitalisasi pasar Artivion Corp|AORT - Nilai Total Perusahaan

- data nilai buku modal saham:

Nilai Buku Saham Artivion|AORT - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku artivion.com|AORT - Total Aset Perusahaan

- rincian utang lan likuiditas:

Rasio Total Utang marang Ekuitas Artivion, Inc.|AORT - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Artivion Corp|AORT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Artivion Corp|AORT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Artivion|Koefisien jangkoan perantara artivion.com

- rincian asil keuangan lan kelipatan valuasi:

AORT - Penghasilan resik

Pambiji fundamental:Artivion, Inc.

Total assets reflect the aggregate value of all resources held by Artivion, Inc. necessary for business operations. The current level of total assets for the company stands at 957.58, calculated inversely via ROA and the sum of liabilities and equity. The dynamics of this metric are sensitive to logistical disruptions in biomaterial supplies and export restrictions, which directly impact the operating value of the implant manufacturer's global infrastructure.

Pesaing utama